We Dissect Protocols

Dimethyl sulfoxide (dmso)

Manufactured by Merck Group
38 579 citations
Sourced in United States, Germany, United Kingdom, China, Italy, France, Sao Tome and Principe, India, Switzerland, Canada, Macao, Australia, Japan, Spain, Belgium, Poland, Austria, Brazil, Czechia, Sweden, Denmark, Israel, Portugal, Netherlands, Hungary, Ireland, Singapore, Indonesia, Argentina, Mexico, New Zealand, Malaysia, Norway, Finland, Slovakia, Bangladesh, Chile, Cameroon, Panama, Thailand, Morocco, Pakistan, Romania, Saudi Arabia, Latvia, Taiwan, Province of China, Croatia, Colombia, Lithuania, Uruguay, Ukraine, Hong Kong, Senegal, Egypt
About the product

DMSO is a versatile organic solvent commonly used in laboratory settings. It has a high boiling point, low viscosity, and the ability to dissolve a wide range of polar and non-polar compounds. DMSO's core function is as a solvent, allowing for the effective dissolution and handling of various chemical substances during research and experimentation.

Automatically generated - may contain errors

Market Availability & Pricing

Dimethyl sulfoxide (DMSO) is an active chemical product manufactured and commercialized by Merck Group. It is available through authorized distributors. Pricing typically ranges from $126.00 for 100 mL to $6,120.00 for 18 L.

Need Operating Instructions, SDS, or distributor details? Just ask our AI Agent.

Is this product still available?

Get pricing insights and sourcing options

38 579 protocols using «dimethyl sulfoxide (dmso)»

1

Proteolytic Activity of P. semirufa Caterpillar Bristle Extract

2025
The proteolytic activity of the P. semirufa caterpillar bristle extract was evaluated using fluorescence resonance energy transfer (FRET) peptide substrates, with readings performed in a spectrofluorometer. For this, the peptide Abz-FRSSRQ-EDDnp was dissolved in 10% dimethyl sulfoxide (DMSO - Merck, Darmstadt, Germany) and then diluted in Milli-Q water to allow the use of volumes where the concentration of the organic solvent did not exceed 5% of the final incubation volume (100 µL). For the assay, samples of the extract (1.0 µg) were incubated with peptide samples (5.0 µM) in buffered saline solution (PBS, pH 7.4) using 96-well plates and analyzed in a spectrofluorometer (FLUOstar Omega, BMG Labtech Inc, Durham, NC, USA) with excitation and emission wavelengths of 320 and 420 nm, respectively. The reaction temperature was maintained at 37 °C in a thermo-stabilized compartment under agitation. The increase in fluorescence was monitored continuously for 15 minutes, and the specific proteolytic activity of the extracts was expressed as µM of substrate cleaved per minute per microgram of extract (U/µg), calculated using the formula: Hydrolysis rate (µM/min)/[prot] (µg).
+ Open protocol
+ Expand
2

Angiotensin II and Angiotensin 1-7 Treatments

2025
Ang II and Ang 1–7 (Sigma-Aldrich) were prepared by dissolving the powder in filtered water to make stock solutions of 10 mM, which were stored at −20 °C. Prior to use, the stock solutions were further diluted with DMEM to achieve the required concentrations (0.1, 1, and 10 µM). AVE0991 was prepared by dissolving the powder in filtered dimethyl sulfoxide (DMSO, Sigma™) to make a stock solution of 1 mM, which was also stored at −20 °C. Prior to use, the stock was further diluted with DMEM to achieve the required concentrations (0.1, 1, and 10 µM). The tested cell lines were treated with Ang II, Ang 1–7, or AVE0991 for various time points (24–96 h). The doses and time points were chosen based on previous reports [9 (link),10 (link),15 (link),18 (link)].
+ Open protocol
+ Expand
3

FXR Agonist Screening and Characterization

2025
All the reagents are of analytical grade. Dimethyl sulfoxide (DMSO) (Cat# 472301), CDCA (Cat# C9377), and TCA sodium salt hydrate (Cat# T4009) were obtained from Sigma. GUDCA (Cat# HY-N1424), GlyMCA (Cat# HY-114392), and sitagliptin (Cat# HY-13749) were sourced from MedChemExpress. GW4064 (Cat# S2782) was acquired from Selleck Co.; OCA (Cat# 459789-99-2) was obtained from Shanghai MissYou Chemical Co., Ltd. Neomycin sulfate (Cat# MB1716), streptomycin sulfate (Cat# MB1275), and bacitracin (Cat# MB1374) were obtained from Dalian Meilun Biological Technology Co., Ltd. The methionine- and choline-sufficient (MCS) diet (Cat# A02082003B), MCD diet (Cat# A02082002B), HFD (Cat# D12492), and GAN diet (Cat# D09100310) were purchased from Research Diets, Inc. TRIeasy total RNA extraction reagent (Cat# 10606ES60), qPCR SYBR Green Master Mix (Cat# 11184ES08), and HiScript III RT SuperMix for qPCR (Cat# R323-01) were sourced from Yeasen Biotechnology (Shanghai) Co., Ltd. Biotin-labeled SRC2-3 peptide (Bio-SRC2-3, Bio-QEPVSPKKKENALLRYLLDKDD TKD) and Biotin-labeled NCoR2 peptide (Biotin-NCoR2, Bio-GHSFADPASNLGLEDIIRK ALMGSF) were synthesized by Shanghai Shenggong Co. Matrigel (Cat# 356255), Dulbecco’s modified Eagle’s medium (DMEM) (Cat# C11995500CP), and fetal bovine serum (FBS) (Cat# 10091148) were obtained from Gibco. Human embryonic kidney (HEK293T) cells were obtained from the American Type Culture Collection (ATCC) cell bank (Cat# CRL-3216). IntestiCult Organoid Growth Medium with Supplements 1 and 2 (Cat# 06005) was obtained from STEMCELL Ltd. FIREFLYGLO Luciferase Assay System (Cat# MA0519) was obtained from Dalian Meilun Biological Technology Co., Ltd. CellTiter-Blue® Cell Viability Assay (G8082) was obtained from Promega Corporation. FXR coactivator recruitment assay kit (Cat# A15140) was obtained from Thermo Fisher Scientific. The histidine detection kit for AlphaScreen assay (Cat# 6760619C) was purchased from PerkinElmer Life Sciences. TG assay kit (Cat# A110-2-1), TC assay kit (Cat# A111-1-1), ALT assay kit (Cat# C009-3-1), and AST assay kit (Cat# C010-2-1) were obtained from Nanjing Jiancheng Bioengineering Institute. The mutation assay was carried out by QuickMutation™ Site-Directed Mutagenesis Kit (Cat# D0206M) from Beyotime Biotechnology. Active GLP-1 kits (Cat# EGLP-35K) were obtained from Millipore Corporation.
+ Open protocol
+ Expand
4

Cytotoxicity Evaluation of Steroid Hormones and BPA

2025
Cell culture reagents DMEM with/without (w/o) phenol red, fetal bovine serum (FBS) and charcoal-stripped (CS-FBS) were purchased from Gibco (Invitrogen Life Technologies, San Giuliano Milanese, Italy) except for penicillin and streptomycin (PS) and dimethyl sulfoxide (DMSO) both bought from Sigma-Aldrich. T47D cells (derived from the pleural effusion of a ductal human carcinoma of the breast) were purchased from ATCC (American Type Culture Collection/LGC Standards SRL). The MCF7 cells were derived from the pleural effusion of a Caucasian female, suffering from a breast adenocarcinoma and kindly provided by the former laboratory of Professor Loreni Fabrizio of the University of Tor Vergata, Rome Italy. MCF7 cells were grown in; DMEM phenol red complete medium (growth medium/GM with FBS 10%) & Treatment Medium containing DMEM without phenol red and 5% CS- FBS); all chemicals were dissolved in DMSO to obtain 100 mM stock solutions. Working stock solutions and dilutions were prepared in 1x GM without FBS and PS just before use to always dilute vehicle (DMSO) concentration to 0.01%. Vehicle treated cells (0.01% DMSO) were used as controls (CTRL) in all experiments, which were conducted as three biological replicates. All cells were maintained in a humidified incubator at 37°C with 5% CO2 concentration. The cytotoxic impact, both alone and in co-treatment of the substances selected for the study, was evaluated on T47D and MCF7 cell cultures in monolayer by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay. Before treatments, the T47D and MCF7 cell lines were plated at a density of 10 × 103 cells/well in 96-well plates in 200 μL TM (Treatment Medium containing DMEM without phenol red and 5% CS- FBS) and incubated for 24 h. Subsequently, the cell lines were then treated for 24 h with the study substances to perform a dose-response curve from 1 pM to 100 μM before assessing cytotoxicity. Likewise, for gene expression, before treatments, T47D and MCF7 cells were plated in 12.5 cm2 flasks (8 × 105 cells/flask) and incubated for 24 h in TM, then washed with 1× phosphate buffer solution/PBS, pH 7.2 w/o Ca2+ and Mg2+ and treated for 24 h with the steroid hormone E2, the plasticizer BPA in the presence or absence of FUL in TM.
+ Open protocol
+ Expand
5

Reagent Procurement for Cell Culture

2025
All the reagents were of analytical grade and used without further purification. AP (Bee and You company, Nazobec (Farmamag İlaç San ve Tic A.Ş., Turkey)), Dulbecco-modified eagle medium (DMEM), fetal bovine serum (FBS), Antibiotic, and dimethyl sulfoxide (DMSO) were purchased from Sigma Aldrich (St. Louis, MO, USA). Primers and regents for gene expression and cDNA analyses by real-time PCR were obtained from Roche (Darmstadt, Germany).
+ Open protocol
+ Expand

Top 5 most cited protocols using «dimethyl sulfoxide (dmso)»

1

Screening for Genes Enabling Robust Growth

The screens for genes required for robust growth were conducted essentially as previously described (Gilbert et al., 2014 (link)). Briefly, plasmid libraries were packaged into lentivirus in HEK293T cells (RRID:CVCL_0063) and infected into a previously established polyclonal K562 cell line stably expressing dCas9-KRAB grown in 3L spinner flasks (Bellco, Vineland, NJ). After two days, infected cells were selected with 0.75 μg/mL puromycin (Tocris, Bristol, UK) for two days, allowed to recover for one day, and then cultured at a minimum of 750 × 106 cells in 1.5L standard media (RPMI-1640 with 10% Fetal Bovine Serum and 1x supplemental glutamine, penicillin, and streptomycin) from 'T0' to 'endpoint,' determined by ~10 cell doublings after T0. CRISPRi screen cells were mock-treated with 0.1% DMSO (Sigma-Aldrich, St. Louis, MO) but otherwise left untreated. Screens were performed as independent replicates starting from the infection step. The K562 dCas9-KRAB and SunTag-VP64 cell lines were obtained from (Gilbert et al., 2014 (link)) and had been constructed from K562 cells originally obtained from ATCC (RRID:CVCL_0004). Cytogenetic profiling by array comparative genomic hybridization (not shown) closely matched previous characterizations of the K562 cell line (Naumann et al., 2001 (link)). All cell lines tested negative for mycoplasma contamination (MycoAlert Kit, Lonza, Basel, Switzerland) in regular screenings.
Frozen samples of 250 × 106 cells collected at T0 and endpoint were processed as previously described (Gilbert et al., 2014 (link)), with the substitution of an SbfI restriction digest (SbfI-HF, New England Biolabs, Ipswich, MA) in place of the MfeI digest in the genomic DNA fragmentation and enrichment step. The sgRNA-encoding regions were sequenced on an Illumina HiSeq-4000 using custom primers. Sequencing reads were aligned to the expected library sequences using Bowtie (v1.0.0, [Ben Langmead et al., 2009 (link)]) and read counts were processed using custom Python scripts (available at https://github.com/mhorlbeck/ScreenProcessing) based on previously established shRNA screen analysis pipelines (Bassik et al., 2013 (link); Kampmann et al., 2013 (link)). sgRNAs represented with fewer than 50 sequencing reads in both T0 and Endpoint were excluded from analysis. sgRNA growth phenotypes (γ) were calculated by normalizing sgRNA log2 enrichment from T0 to endpoint samples and normalizing by the number of cell doublings in this time period. CRISPRi v1 screen data from Gilbert et al. (2014) (link) was re-analyzed using this pipeline, and the hCRISPRi/a-v2 5 sgRNA/gene libraries were evaluated by analyzing the sgRNA read counts corresponding to only the 5 sgRNA/gene sublibraries. Gene ontology analysis was conducted using DAVID 6.7 (Huang et al., 2009 (link)) with default search categories and with background lists representing the genes targeted by the CRISPRa v1 or hCRISPRa-v2 libraries where appropriate. For Figure 4B and Figure 4—figure supplement 1D, 'shared hit' genes were 70 genes that scored as strong anti-growth hits (phenotype z-score x –log10 p-value ≤ −10) in both CRISPRa v1 and hCRISPRa-v2.
+ Open protocol
+ Expand

Corresponding organizations : University of California, San Francisco, Howard Hughes Medical Institute, Innovative Genomics Institute, University of California, Berkeley, Institute for Neurodegenerative Disorders

2

Induction of Mitosis Arrest and Apoptosis

The inhibition of mitosis and the induction of apoptosis in KG1a and MV4–11 cells were induced respectively by exposure to camptothecin (Sigma-Aldrich, Saint-Quentin Fallavier, France), a cytotoxic quinoline alkaloid which inhibits the DNA enzyme topoisomerase I [10] (link), [11] (link) and by AZD8055 (AstraZeneca Cancer & Infection Research Area, Alderley Park, UK) [12] (link), a selective inhibitor of mTOR kinase, respectively. Cells were seeded at 2×105 cells/mL (5% CO2 incubator at 37°C). KG1a cells were cultured for 6h with camptothecin at a final concentration of 1 µM and MV4–11 cells were cultured for 24 h with AZD8055 at a final concentration of 10 nM and 100 nM. The stock solutions were diluted to ensure a final concentration of <0.03% for DMSO (Sigma-Aldrich). Control cultures were treated with an equivalent volume of DMSO in MEM alpha medium which did not induce apoptosis.
Quiescence was induced in KG1a cells by contact with BM MSCs [13] (link). Adherent culture-amplified MSCs were used at passage 2 (P2). KG1a cells were co-cultured on P2-MSCs for 72 h (37°C in 95% humidified air and 5% CO2) at a starting concentration of 1.5×104/cm2.
The accumulation of KG1a cells in the M phase was induced by exposure to colcemid (KaryoMax Colcemid, Life Technologies), used for arresting the dividing cell at metaphase of mitosis. Cells were cultured 30 min and 1 h with colcemid at a final concentration of 0.1 µg/mL.
Lymphocytes stimulation was induced by exposure to phytohemagglutinin (PHA) (Remel™, Oxoid™, Haarlem, The Netherlands), which is used to stimulate mitotic division of lymphocytes. Whole blood cells were cultured 72 h with PHA at a final concentration of 170 µg/mL according to the manufacturer’s recommandations.
All experiments were performed in triplicate.
+ Open protocol
+ Expand

Corresponding organizations : Université de Tours, Centre National de la Recherche Scientifique, Centre Hospitalier Universitaire de Tours, Institut Cochin, Université Paris Cité

3

In Vitro Antifilarial Drug Screening

Individual adult Brugia malayi female worms (TRS Labs Inc., Athens, GA) were assayed in RPMI-1640 (25 mM HEPES, 2 g/L , Antibiotic/Antimycotic, 5% HI FBS) in 24-well tissue culture plates (1 worm/well). 30 mM stock solutions of albendazole (methyl 5-(propylthio)-2-benzimidazolecarbamate, Sigma), ivermectin (22,23-dihydroavermectin B1, Sigma) and fenbendazole (methyl 5-(phenylthio)-2-benzimidazolecarbamate, Sigma) were prepared with DMSO (Sigma) and serially diluted in media into concentrations of , , , , . DMSO was used as the control and each concentration was run in triplicate. Plates were maintained in a 37 C 5% incubator for 48 hours. data were calculated using Microsoft Excel (Microsoft Corp.) and Prism 5 (GraphPad Software, Inc.).
+ Open protocol
+ Expand

Corresponding organizations : Case Western Reserve University, University School, University of California, San Francisco, San Francisco State University

4

PC12 Cell Culture and Differentiation

Because of the clonal instability of the PC12 cell line (Fujita et al. 1989 (link)), the experiments were performed on cells that had undergone fewer than five passages, and all studies were repeated several times with different batches of cells. As described previously (Crumpton et al. 2000a (link); Qiao et al. 2003 (link); Song et al. 1998 (link)), PC12 cells (1721-CRL; American Type Culture Collection, Manassas, VA) were seeded onto 100-mm poly-d-lysine-coated plates in RPMI-1640 medium (Invitrogen, Carlsbad, CA) supplemented with 10% inactivated horse serum (Sigma Chemical Co., St. Louis, MO), 5% fetal bovine serum (Sigma Chemical Co.), and 50 μg/mL penicillin streptomycin (Invitrogen). Cells were incubated with 7.5% CO2 at 37°C, and the medium was changed every 2 days. For studies in the undifferentiated state, cells were seeded at varying densities so that, regardless of the total time of incubation, the cells would reach a final confluence of 60–70%. Twenty-four hours after seeding, the medium was changed to include the various test substances: chlorpyrifos (Chem Service, West Chester, PA), diazinon (Chem Service), parathion (Chem Service), physostigmine (Sigma Chemical Co.), dieldrin (Chem Service), or NiCl2 (Sigma Chemical Co.). Because of their poor water solubility, the pesticides were dissolved in dimethyl sulfoxide (Sigma Chemical Co.), achieving a final concentration of 0.1% in the culture medium; accordingly, all cultures included this vehicle, which had no effect on the PC12 cells (Qiao et al. 2001 (link), 2003 (link); Song et al. 1998 (link)).
For studies in differentiating cells, 3 × 106 cells were seeded; 24 hr later, the medium was changed to include 50 ng/mL 2.5 S murine NGF (Invitrogen), and each culture was examined under a microscope to verify the subsequent outgrowth of neurites. The test agents were added concurrently with the start of NGF treatment.
+ Open protocol
+ Expand

Corresponding organizations : Duke University

5

Fungal DNA Extraction and Amplification Protocols

For the primers inferred from the complete genome through the approach by Robert et al. (2011) , total genomic DNA was extracted from living cultures, cells preserved in liquid nitrogen or in lyophilisation and from dried fungarium specimens (Agaricomycotina only) using different variations of one-by-one or high-throughput 96-well plate DNA extraction techniques, routinely used by the respective collaborating laboratories (Ferrer et al. 2001 (link), Ivanova et al. 2006 , Yurkov et al. 2012 (link), 2015 , Feng et al. 2013 (link), Verkley et al. 2014 (link)). DNA extraction and PCR protocols differed between participating laboratories.
Primers and amplification conditions used varied between laboratories, an example of the ones used at the CBS is provided. PCR reactions for amplification of the ITS barcode employed primers ITS5/ITS1/ITS1F and ITS4 were performed under standard or semi-nested conditions in 12.5 μL reactions (the CBS-KNAW barcoding lab protocol) containing 2.5 μL purified DNA, 1.25 μL PCR buffer (Takara, Japan, incl. 2.5 mM MgCl2), 1 μL dNTPs (1 mM stock; Takara, Japan), 0.6 μL v/v DMSO (Sigma, Netherlands), forward-reverse primer 0.25 μL each (10 mM stock), 0.06 μL (5 U) Takara HS Taq polymerase, 7.19 μL MilliQ water (White et al. 1990 , Stielow et al. 2012 , Yurkov et al. 2012 (link)). PCR conditions for amplifying partial LSU rDNA using primers LR0R and LR5 differed only by their annealing temperature (55 °C instead of 60 °C) and increased cycle extension time (90 s per cycle). Amplification of partial γ-actin (ACT), covering the more variable 5’-end including two small introns, and partial β -tubulin 2 (TUB2), covering the variable 5’-end with up to four small introns, followed the protocol of Aveskamp et al. (2009) (link) and Carbone & Kohn (1999) using the primers Btub2Fd and Btub4Rd, and ACT-512F, ACT-783R, respectively. TEF1α and RPB2 were amplified following the protocols of Rehner & Buckley (2005) (link) and Liu et al. (1999) (link), respectively (Table 2). PCR products were directly purified using FastAP thermosensitive alkaline phosphatase and shrimp alkaline phosphatase (Fermentas, Thermo Fisher Scientific). Cycle-sequencing reactions were set up using ABI BigDye Terminator v. 3.1 Cycle Sequencing kit (Thermo Fisher Scientific), with the manufacturers’ protocol modified by using a quarter of the recommended volumes, followed by bidirectional sequencing with a 3730xl DNA Analyser (Thermo Fisher Scientific). Sequences were archived, bidirectional reads assembled and manually corrected for sequencing artefacts using BioloMICS software v. 8.0 (www.bio-aware.com) (Vu et al. 2012 (link)). Edited sequences were exported to and aligned with MAFFT v. 7.0 (Katoh et al. 2005 (link)) and further corrected for indels and SNPs (single nucleotide polymorphisms) by replacing respective positions with ambiguity code letters.
For the primers inferred from the complete proteome through the Pfam approach by Lewis et al. (2011) , genomic DNA from fungal cultures was extracted using the OmniPrep™ Genomic DNA Extraction Kit (G-Biosciences, St. Louis, Missouri). Fungal tissue was ground into a fine powder in a mortar and pestle with liquid nitrogen and stored at -80 °C. Approximately 50 mg of ground tissue was placed in a 1.7 mL microfuge tube, resuspended in 250 μL of lysis buffer and vortexed for several seconds. An additional 250 μL of lysis buffer was added to the resuspension and the tube was incubated for 15 min at 55–60 °C without the addition of Proteinase K. The samples were cooled to room temperature and 200 μL of chloroform was added to the tube. The tube was mixed by inversion several times and then centrifuged for 10 min at 14 000 ×g. The upper aqueous phase was removed to a new microfuge tube and 100 μL of precipitation solution was added. If no white precipitate was produced an additional 50 μL of precipitation solution was added to the tube. The white precipitate was pelleted by centrifugation and the supernatant was moved to a fresh tube. The genomic DNA was precipitated by the addition of 500 μL of isopropanol to the supernatant and inversion of the tube several times. The genomic DNA was pelleted by centrifugation and washed with 700 μL of 70 % ethanol. The ethanol was decanted and the pellet was air dried for 15 s prior to resuspension in 50 μL of TE Buffer. DNA concentration was determined using the Qubit® 2.0 Fluorometer (Life Technologies, Burlington, Canada) and working solutions were prepared at a concentration of 0.05 ng/μL. PCR was carried out on 0.1 ng of genomic DNA in a total volume of 20 μL using 0.2 mM dNTPs, 0.5 μM of each primer, 1× of Titanium Taq Buffer and Titanium Taq DNA Polymerase (Clontech) using an Eppendorf GradientS thermal cycler. For the ITS primers, an initial denaturation at 95 °C for 3 min was followed by 40 cycles at the following conditions: 30 s at 95 °C, 45 s at 58 °C and 2 min at 72 °C. A final extension at 72 °C for 8 min completed the PCR. For the remaining primers, Touchdown PCR was performed where an initial denaturation at 95 °C for 5 min was followed by 10 cycles of 45 s at 95 °C, 45 s starting at 68 °C and dropping by 1 °C per cycle until a temperature of 58 °C was reached and a 1 min extension at 72 °C. The initial 10 cycles were then followed by 35 cycles of 45 s at 95 °C, 45 s at 58 °C and 1 min at 72 °C. A final extension at 72 °C for 5 min completed the PCR.
+ Open protocol
+ Expand

Corresponding organizations : Alberta Biodiversity Monitoring Institute, Westmead Institute for Medical Research, Biodiversité et Biotechnologie Fongiques, Laboratoire de Recherche en Sciences Végétales, Naturalis Biodiversity Center, Senckenberg Research Institute and Natural History Museum Frankfurt/M, Fraunhofer Institute for Interfacial Engineering and Biotechnology, Leibniz Institute DSMZ – German Collection of Microorganisms and Cell Cultures, Ruhr University Bochum, Microbiologie de l’alimentation au service de la santé, RMIT University, Centre National de la Recherche Scientifique, Shanghai Changzheng Hospital, Al-Azhar University

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!

🧪 Need help with an experiment or choosing lab equipment?
I search the PubCompare platform for you—tapping into 40+ million protocols to bring you relevant answers from scientific literature and vendor data.
1. Protocol search & design
(papers, patents, application notes)
2. Protocol validation
(from literature and MDAR)
3. Lab Product search
4. Product validation from literature
5. Troubleshoot product/ protocol
6. Instant figure generation New
Want to copy this response? Create your account to unlock copy/paste and export options.